CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancer-Reference-Cited by-同舟云学术

CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancer

Published:2020-12-04 Issue:2 Volume:253 Page:234-245
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Viotto Davide¹,Russo Francesca¹²,Anania Ilaria¹,Segatto Ilenia¹,Rampioni Vinciguerra Gian Luca¹³,Dall'Acqua Alessandra¹,Bomben Riccardo⁴,Perin Tiziana⁵,Cusan Martina¹,Schiappacassi Monica¹,Gerratana Lorenzo⁶⁷,D'Andrea Sara¹,Citron Francesca¹,Vit Filippo²⁴,Musco Lorena¹²,Mattevi Maria Chiara¹,Mungo Giorgia¹,Nicoloso Milena S¹⁶,Sonego Maura¹,Massarut Samuele⁸,Sorio Roberto⁶,Barzan Luigi⁹,Franchin Giovanni¹⁰,Giorda Giorgio¹¹,Lucia Emilio¹¹,Sulfaro Sandro¹²,Giacomarra Vittorio⁹,Polesel Jerry¹³,Toffolutti Federica¹³,Canzonieri Vincenzo⁵¹⁴,Puglisi Fabio⁶⁷,Gattei Valter⁴,Vecchione Andrea³,Belletti Barbara¹^ORCID,Baldassarre Gustavo¹^ORCID

Affiliation:

1. Molecular Oncology Unit Centro di Riferimento Oncologico di Aviano (CRO Aviano), IRCCS, National Cancer Institute Aviano Italy

2. University of Trieste Trieste Italy

3. Department of Clinical and Molecular Medicine University of Rome ‘Sapienza’, Sant'Andrea Hospital Rome Italy

4. Onco‐Hematology Unit Centro di Riferimento Oncologico di Aviano (CRO Aviano), IRCCS, National Cancer Institute Aviano Italy

5. Pathology Unit Centro di Riferimento Oncologico di Aviano (CRO Aviano), IRCCS, National Cancer Institute Aviano Italy

6. Department of Medical Oncology Centro di Riferimento Oncologico di Aviano (CRO Aviano), IRCCS, National Cancer Institute Aviano Italy

7. Department of Medicine (DAME) University of Udine Udine Italy

8. Breast Surgery Unit Centro di Riferimento Oncologico di Aviano (CRO Aviano), IRCCS, National Cancer Institute Aviano Italy

9. Division of Otorhinolaryngology General Hospital of Pordenone Santa Maria degli Angeli Pordenone Italy

10. Radiotherapy Unit Centro di Riferimento Oncologico di Aviano (CRO Aviano), IRCCS, National Cancer Institute Aviano Italy

11. Gynecological Surgery Unit Centro di Riferimento Oncologico di Aviano (CRO Aviano), IRCCS, National Cancer Institute Aviano Italy

12. Unit of Pathology General Hospital of Pordenone Santa Maria degli Angeli Pordenone Italy

13. Cancer Epidemiology Unit Centro di Riferimento Oncologico di Aviano (CRO Aviano), IRCCS, National Cancer Institute Aviano Italy

14. Department of Medical, Surgical and Health Sciences University of Trieste Trieste Italy

Funder

Associazione Italiana per la Ricerca sul Cancro

Ministero della Salute

Regione Autonoma Friuli Venezia Giulia

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/path.5584

Reference40 articles.

1. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

2. Somatic mutation of CDKN1B in small intestine neuroendocrine tumors

3. Multiple Endocrine Neoplasia Type 4

4. A Syndrome of Multiorgan Hyperplasia with Features of Gigantism, Tumorigenesis, and Female Sterility in p27Kip1-Deficient Mice

5. The murine gene p27Kip1 is haplo-insufficient for tumour suppression

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Loss of the extracellular matrix glycoprotein EMILIN1 accelerates Δ16HER2-driven breast cancer initiation in mice;npj Breast Cancer;2024-01-06

2. Low CDKN1B Expression Associated with Reduced CD8+ T Lymphocytes Predicts Poor Outcome in Breast Cancer in a Machine Learning Analysis;Journal of Personalized Medicine;2023-12-25

3. Integration of genomics and transcriptomics highlights the crucial role of chromosome 5 open reading frame 34 in various human malignancies;Aging;2023-12-07

4. Multiple endocrine neoplasia type 4 (MEN4): a thorough update on the latest and least known men syndrome;Endocrine;2023-08-26

5. A pan-cancer analysis for the oncogenic role of cyclin-dependent kinase inhibitor 1B in human cancers;Discover Oncology;2023-07-11